Acute Stroke Treatment:
Stroke is one of the leading causes of long-term adult disability, affecting approximately 795,000 people each year in the U.S. Many studies have identified patient failure to arrive at the hospital in time for treatment following the stroke symptom onset as the key barrier to increasing rates of thrombolytic treatment. Stroke center personnel agree that public lack of knowledge about the appropriate response to stroke symptoms is a key barrier to stroke treatment—a barrier that has proven intransigent to many and diverse interventions.
The Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds program provides a succinct update on key new evidence about acute stroke care, especially care in the emergency department, where the speed and accuracy of diagnosis and treatment can have profound long-term impacts on patient quality of life.
To educate learners on the most common missed opportunities in acute ischemic stroke in an effort to increase diagnosis and treatment to improve patient outcomes.
Goals and Learning Objectives
The goal of the Acute Stroke Treatment: Addressing Missed Opportunities virtual grand rounds activity is to promote the reduction in time to treat and facilitate increased treatment rates for acute ischemic stroke. Through participation in these activities, learners will be able to:
- Discuss the rationale for earliest possible treatment
- Identify potential targets for improving times to treat in the emergency department
- Describe characteristics that can lead to delayed or missed diagnosis and/or treatment
- Discuss the rationale for evolving and modifying exclusion criteria, based on evidence
- Identify relevant targets for improvement within their respective hospitals, to either decrease time to treat or increase rates of treatment
The target audience for the Acute Stroke Treatment: Addressing
Missed Opportunities virtual grand rounds activity includes emergency
medicine physicians and nurses, neurologists and neuroscience nurses. Because
in-hospital strokes account for approximately 15 percent of all strokes, the
program also will target ICU and other nurses, hospitalists and other
hospital-based professionals who care for stroke patients.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and National Stroke Association. MER is accredited by the ACCME to provide continuing medical education for physicians.
Medical Education Resources designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.
For questions regarding this activity, please contact Medical Education Resources at firstname.lastname@example.org or National Stroke Association at email@example.com.
This enduring virtual grand round is designed for individual viewing. The post-test and evaluation are electronic and can only be completed by an individual after watching the program. There are no fees for participating in and receiving credit for this activity.
During the period from Nov. 1, 2013 through Nov. 1, 2014, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the post-test by recording the best answer to each question, 4) complete the evaluation form and 5) click on “Submit” to return to National Stroke Association.
Edward Jauch, MD, MS
Professor, Interim Chief, Division of Emergency Medicine
Associate Vice Chair, Research
Department of Medicine Professor
Department of Neurosciences - Medical University of South Carolina Charleston, S.C.
David Liebeskind, MD, FAHA, FAAN
Professor of Neurology
Neurology Director, Stroke Imaging Co-medical and Co-technical Director, UCLA Cerebral Blood Flow Laboratory Program
Director, Stroke and Vascular Neurology Residency
Associate Neurology Director, UCLA Stroke Center
Los Angeles, Calif.
Disclosure of Conflict of Interest
Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all its educational activities. In accordance with this policy, Medical Education Resources identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Medical Education Resources resolves conflicts to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. Medical Education Resources is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
|Name of Faculty
||Reported Financial Relationship|
|Dr. Ed Jauch||Consultant Roche Diagnostic|
|Dr. David Liebeskind||Consultant NIH-NINDS, Stryker, Covidien, CoAxia|
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Kim Bova, BSN, RN, CCRN, CEN, No
financial relationship to disclose
Amy Jensen, National Stroke Association, No financial relationship to disclose
Michelle Murdock, Consultant, No financial relationship to disclose
Veronda Smith, FNP-BC, No financial relationship to disclose
Julie Johnson, PharmD, No financial relationship to disclose
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Genentech. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Genentech. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.